CBS News1h
Lawyers for ex-Abercrombie CEO say he has dementia and may not be able to stand trial
Michael Jeffries, the former longtime CEO of Abercrombie & Fitch, may have dementia, and a competency hearing is needed to determine if he can face sex charges, his attorneys claim. Defense ...
The Express Tribune16h
Former Abercrombie & Fitch CEO Mike Jeffries diagnosed with dementia amid sex trafficking charges
Mike Jeffries, the former CEO of Abercrombie & Fitch, has been diagnosed with dementia and late-onset Alzheimer’s disease ...
KING521h
Ex-Abercrombie CEO may have dementia, potentially leaving him incompetent to face sex charges, lawyers say
CENTRAL ISLIP, N.Y. — Defense lawyers say the former longtime CEO of Abercrombie & Fitch may have dementia, and a ...
Abercrombie & Fitch Co. (NYSE:ANF) Receives $179.50 Consensus Price Target from Brokerages
Shares of Abercrombie & Fitch Co. (NYSE:ANF – Get Free Report) have received an average recommendation of “Moderate Buy” from ...
Abercrombie & Fitch target raised, placed on Positive Catalyst Watch at JPMorgan
JPMorgan raised the firm’s price target on Abercrombie & Fitch to $204 from $201 and keeps an Overweight rating on the shares, which the ...
Abercrombie & Fitch: Nearly The Cheapest It's Ever Been, Double-Digit Growth Remains
Abercrombie & Fitch reports strong sales growth and margin expansion, raising guidance for FY2024. Click here to read an analysis of ANF stock now.